Healthcare | December 30, 2022
Eye-Q inaugurates its new facility in Yamunanagar
The new facility will be able to handle four times as many patients as the previous facility.
The new facility will be able to handle four times as many patients as the previous facility.
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The organisation is also working towards providing skills based training programmes to the workers for paramedical jobs and has launched certificate courses in ten disciplines
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
He has published more than 100 research papers in several prestigious national and international journals
Subscribe To Our Newsletter & Stay Updated
